Abstract
Inulin enzymatically synthesized from sucrose is a dietary component that completely escapes glucide digestion. Supplementing inulin to a high-fat and high-sucrose diet (HF) ameliorated hypertriglycemia and hepatic steatosis in 8-week-fed rats by suppressing elevated levels of serum triacylglycerols, fatty acids, and glucose, and the accumulation of hepatic triacylglycerols and fatty acids. Inulin intake prevented phenobarbital (PB)- and dexamethasone-induced liver injuries in the HF group. No significant alteration in the baseline expression of CYP2B, CYP2C11, CYP3A, and NADPH-cytochrome P450 (P450) reductase mRNAs and proteins was found. In contrast, baseline and PB-treated expressions of CYP2E1 mRNA were reduced in HF-fed rats. The induction of P450s in response to PB was affected by the nutritional status of the rats; mRNA levels of CYP2B1 and CYP3A1 after PB treatment, as assessed by quantitative real-time polymerase chain reaction analysis were reduced in the inulin-supplemented HF (HF+I) group, compared with those in the HF group. Western blot analysis detected the corresponding changes of CYP2B and CYP3A proteins. These alterations were correlated with changes in hepatic thiobarbituric acid-reactive substances. Furthermore, no significant difference in the expression of nuclear receptors constitutive androstane receptor, pregnane X receptor, and retinoid X receptor α and coactivator peroxisome proliferator-activated receptor-γ coactivator 1α proteins was found in the hepatic nucleus between the HF and HF+I groups, but the expression of hepatocyte nuclear factor α (HNF4α) protein was significantly reduced in the HF+I group. Taken together, these results indicate that inulin intake ameliorates PB-induced liver injury, associated with a decline in lipid accumulation and PB-induced expression of CYP2B and CYP3A, which may be related by a reduction in the nuclear expression of HNF4α.
Footnotes
-
This work was in part supported by the COE21 Program, Grant-in-Aid for Scientific Research (15590063, 16590056), and Cooperation of Innovative Technology and Advanced Research in Evolutional Area (CITY AREA) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.
-
Article, publication date, and citation information can be found at http://dmd.aspetjournals.org.
-
doi:10.1124/dmd.106.010645.
-
ABBREVIATIONS: P450, cytochrome P450; CAR, constitutive androstane receptor; DEX, dexamethasone; HF, high-fat and high-sucrose diet; HF+I, inulin-supplemented HF; HNFα, hepatocyte nuclear factor α; PB, phenobarbital; PGC1α, peroxisome proliferator-activated receptor-γ coactivator 1α; PROD, pentoxyresorufin O-dealkylase; PXR, pregnane X receptor; RXRα, retinoid X receptor α; SD, standard diet; SD+I, inulin-supplemented SD; TBARS, thiobarbituric acid-reactive substances; TNFα, tumor necrosis factor α; HE, hematoxylin-eosin; AST, aspartate aminotransferase; ALT, alanine aminotransferase; γ-GTP, γ-glutamyltranspeptidase.
-
↵
The online version of this article (available at http://dmd.aspetjournals.org) contains supplemental material.
- Received April 15, 2006.
- Accepted June 27, 2006.
- The American Society for Pharmacology and Experimental Therapeutics
DMD articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|